Abstract
One hundred and fifty-four clinical isolates ofKlebsiella pneumoniae resistant to broad-spectrum cephalosporins, aztreonam and amikacin were responsible for an outbreak of nosocomial infections lasting eight months in a university hospital in Paris. This outbreak occurred in the intensive care unit (39 patients), haematology units (8 patients) and surgical and medical units (11 patients). Antibiotic resistant strains were isolated from the urinary tract (48 %), wound and drainage fluids (21 %), respiratory tract (14 %), blood (12 %) and stools (5 %). High resistance to oxyimino-beta-lactams was mediated by a plasmid-encoded beta-lactamase with an isoelectric point of 7.8 (SHV-4). This CAZ-type enzyme conferred a higher level of resistance to ceftazidime and aztreonam (geometric mean MIC 135 mg/l) than to cefotaxime (geometric mean MIC 14 mg/l). All isolates were of the same biotype (weakly urease positive and no sucrose fermentation). EightKlebsiella pneumoniae strains isolated in different units and at different times of the outbreak were of the same serotype, had common plasmid patterns and harboured a large self-transferable plasmid of about 180 kilobases encoding resistance to penicillins, oxyimino-beta-lactams, aminoglycosides, tetracycline and trimethoprim. These eight large plasmids had indistinguishableEcoRI restriction patterns. These results suggest that a single strain ofKlebsiella pneumoniae was responsible for this outbreak.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Casewell MW, Phillips I: Aspect of the plasmid-mediated antibiotic resistance and epidemiology ofKlebsiella species. American Journal of Medicine 1981, 70: 459–462.
Sadowski PL, Peterson BC, Gerding DN, Cleary PP: Physical characterization of ten R plasmids obtained from an outbreak of nosocomialKlebsiella pneumoniae infections. Antimicrobial Agents and Chemotherapy 1979, 15: 616–624.
Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J: Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistantKlebsiella pneumoniae. Lancet 1987, ii: 302–306.
Sirot J, Chanal C, Petit A, Sirot D, Labia R, Gerbaud G:Klebsiella pneumoniae and otherEnterobacteriaceae producing novel plasmid-mediated beta-lactamases markedly active against third-generation cephalosporins: epidemiologic studies. Reviews of Infectious Diseases 1988, 10: 850–859.
Jarlier V, Nicolas MH, Fournier G, Philippon A: Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents inEnterobacteriaceae: hospital prevalence and susceptibility patterns. Reviews of Infectious Discases 1988, 10: 867–878.
Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A, Perroux R, Cluzel R: Transferable resistance to third-generation cephalosporins in clinical isolates ofKlebsiella pneumoniae. Identification of CTX-1, a novel beta-lactamase. Journal of Antimicrobial Chemotherapy 1987, 20: 323–334.
Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B: Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 1985, 28: 302–307.
Barthélémy M, Péduzzi J, Ben Yaghlane H, Labia R: Single amino acid substitution between SHV-1 betalactamase and cefotaxime-hydrolyzing SHV-2 enzyme. FEBS Letters 1988, 231: 217–220.
Sougakoff W, Goussard S, Courvalin P: The TEM-3 beta-lactamase, which hydrolyzes broad-spectrum cephalosporins, is derived from the TEM-2 penicillinase by two amino acid substitutions. FEMS Microbiology Letters 1988, 56: 343–348.
Nicolas MH, Jarlier V, Honoré N, Philippon A, Cole S: Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates ofKlebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 1989, 33: 2096–2100.
Philippon A, Labia R, Jacoby G: Extended-spectrum beta-lactamases. Antimicrobial Agents and Chemotherapy 1989, 33: 1131–1136.
Buré A, Legrand P, Arlet G, Jarlier V, Paul G, Philippon A: Dissemination in five French hospitals ofKlebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. European Journal of Clinical Microbiology and Infectious Diseases 1988, 7: 780–782.
Péduzzi J, Barthélémy M, Tiwari K, Mattioni D, Labia R: Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 beta-lactamase. Antimicrobial Agents and Chemotherapy 1989, 33: 2160–2163.
Legrand P, Fournier G, Buré A, Jarlier V, Nicolas MH, Decré D, Duval J, Philippon A: Detection of extended broad-spectrum beta-lactamases inEnterobacteriaceae in four French hospitals. European Journal of Clinical Microbiology and Infectious Diseases 1989, 8: 527–529.
Matthew M, Harris AM, Marshall H, Ross GW: The use of analytic isoelectric focusing for detection and identification of beta-lactamases. Journal of General Microbiology 1975, 88: 169–178.
Takahashi S, Nagano Y: Rapid procedure for isolation plasmid DNA and application to epidemiological analysis. Journal of Clinical Microbiology 1984, 20: 608–613.
Le Gall JR, Loirat Ph, Alperovitch A: Simplified acute physiological score for intensive care patients. Lancet 1983, ii: 741.
Richard C: Bacteriologie et épidémiologie des espèces du genreKlebsiella. Bulletin de l'Institut Pasteur 1982, 80: 127–145.
Gutmann L, Ferré B, Goldstein FW, Rizk N, Pinto-Schuster E, Acar JF, Collatz E: SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrobial Agents and Chemotherapy 1989, 33: 951–956.
Kitzis MD, Billot-Klein D, Goldstein FW, Williamson R, Tran Van Nhieu G, Carlet J, Acar JF, Gutmann L: Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors. Antimicrobial Agents and Chemotherapy 1988, 32: 9–14.
Nassif X, Sansonetti PJ: Correlation of the virulence ofKlebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin. Infection and Immunity 1986, 54: 603–608.
Nassif X, Fournier JM, Arondel J, Sansonetti PJ: Mucoid phenotype ofKlebsiella pneumoniae is a plasmid-encoded virulence factor. Infection and Immunity 1989, 57: 546–552.
Mayon-White RT, Ducel G, Kereselidze T, Tikorimov E: An international survey of the prevalence of hospital-acquired infection. Journal of Hospital Infection 1988, 11: 43–48.
Brun-Buisson C, Legrand P, Rauss A, Richard C, Montravers F, Beshes M, Meakins JL, Soussy CJ, Lemaire F: Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Annals of Internal Medicine 1989, 110: 873–881.
Philippon A, Ben Redjeb S, Fournier G, Ben Hassen A: Epidemiology of extended spectrum beta-lactamases. Infection 1989, 17: 347–354.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arlet, G., Sanson-le Pors, M.J., Rouveau, M. et al. Outbreak of nosocomial infections due toKlebsiella pneumoniae producing SHV-4 beta-lactamase. Eur. J. Clin. Microbiol. Infect. Dis. 9, 797–803 (1990). https://doi.org/10.1007/BF01967377
Issue Date:
DOI: https://doi.org/10.1007/BF01967377